Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05757778 · ClinicalTrials.gov registry record · NA
Split Chest Breast Neurotization
A NA study of Breast Implant; Complications, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT05757778: Active NA study of Breast Implant; Complications, sponsored by NYU Langone Health.
NCT05757778 is a NA study of Breast Implant; Complications that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05757778, a NA study of Breast Implant; Complications, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Several members of the scientific community have suggested that breast neurotization can help return nipple sensation to patients undergoing implant-based breast reconstruction. There has been no randomized controlled study assessing the validity of these claims. The goal of this study is to evaluate if performing breast neurotization can help restore or improve return of nipple sensation to patients undergoing implant-based breast reconstruction. This will be a single-blinded, randomized controlled trial where patients undergoing bilateral reconstruction will serve as their own controls by receiving an intervention on one breast but not the other breast.
Primary Outcome
SWMT will be used for assessment of breast sensation by applying the monofilament to a given anatomic region. Based on the monofilament size, a score of 0-6 is assigned. Scores are classified as follows: 6 = normal; 5 = diminished light touch; 4 = diminished protective sensation; 3 = loss of protective sensation; 2 = Loss of protective/sensation; 1 = Deep pressure sensation only; and 0 = Loss of sensation.
Conditions Studied
Interventions
- PROCEDURE Sensory Nerve Coaptation
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2027-04-07 |
| Phase | NA |
What the registry record for NCT05757778 still lists
NCT05757778 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Breast Implant; Complications appearing as the primary indexed condition, and to 1 intervention - of which Sensory Nerve Coaptation is the first listed.
NCT05757778 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05757778 about?
NCT05757778 is a clinical study titled "Split Chest Breast Neurotization". Several members of the scientific community have suggested that breast neurotization can help return nipple sensation to patients undergoing implant-based breast reconstruction. There has been no randomized controlled study assessing the validity of these claims. The goal of this study is to evaluat...
What is the current status of trial NCT05757778?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2023-08-08. Estimated completion is 2027-04-07.
What conditions does trial NCT05757778 study?
This clinical trial studies the following conditions: Breast Implant; Complications.
What interventions are being tested in trial NCT05757778?
The interventions under investigation include: Sensory Nerve Coaptation (PROCEDURE).
Who is sponsoring clinical trial NCT05757778?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05757778 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Implant; Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05757778's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI